Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
University Hospital Cologne · University of Cologne · +21 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
1,863
total citations
- FWCI
- 66.80
- Percentile
- 100%
- References
- 44
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Chemoimmunotherapy
- Fludarabine
- Medicine
- Ofatumumab
- Rituximab
- Cyclophosphamide
- Obinutuzumab
- Internal medicine
No related works found for this paper.